iCAD (NASDAQ:ICAD) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of iCAD (NASDAQ:ICAD) in a research note published on Monday morning. The firm issued a sell rating on the technology company’s stock.

A number of other analysts also recently weighed in on the stock. BTIG Research downgraded shares of iCAD from a “buy” rating to a “neutral” rating in a research report on Wednesday, April 16th. Craig Hallum downgraded shares of iCAD from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, April 16th. Finally, Laidlaw reissued a “hold” rating on shares of iCAD in a research report on Thursday, April 17th.

iCAD Price Performance

NASDAQ:ICAD opened at $3.91 on Monday. The firm’s 50-day moving average price is $2.58 and its 200-day moving average price is $2.35. The company has a market capitalization of $107.31 million, a PE ratio of -30.08 and a beta of 1.35. iCAD has a 1-year low of $1.18 and a 1-year high of $4.00.

iCAD (NASDAQ:ICAD) last released its earnings results on Tuesday, May 13th. The technology company reported ($0.02) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.04. The firm had revenue of $4.87 million for the quarter, compared to the consensus estimate of $4.54 million. iCAD had a negative net margin of 17.81% and a negative return on equity of 15.65%.

Institutional Trading of iCAD

Several institutional investors have recently bought and sold shares of ICAD. waypoint wealth counsel grew its position in iCAD by 44.0% during the 4th quarter. waypoint wealth counsel now owns 14,400 shares of the technology company’s stock valued at $26,000 after purchasing an additional 4,400 shares during the last quarter. Summit Trail Advisors LLC purchased a new stake in shares of iCAD during the 4th quarter valued at about $214,000. Thompson Davis & CO. Inc. purchased a new stake in shares of iCAD during the 4th quarter valued at about $31,000. First Eagle Investment Management LLC boosted its holdings in shares of iCAD by 6.1% during the 4th quarter. First Eagle Investment Management LLC now owns 716,161 shares of the technology company’s stock valued at $1,311,000 after acquiring an additional 41,000 shares during the last quarter. Finally, PKS Advisory Services LLC purchased a new stake in shares of iCAD during the 4th quarter valued at about $53,000. 24.61% of the stock is owned by hedge funds and other institutional investors.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.